MD, PhD, Fulbright Scholar (UCLA; W.G. Walker). "I joined CNSDose to promote our evidence-based,
scalable and personalized technology to reduce the suffering caused by trial-and-error prescribing.
I look forward to our bringing other high-value mental health solutions to the market". Harris specialises in precision psychiatry innovation. He brings a diverse background converging
his experience in clinical psychiatry, neuroscience, clinical research, diplomacy, public health,
health system management and technology. Harris has published 80 scientific articles, presents
frequently at international conferences, peer-reviews top scientific journals. He is
Entrepreneur-in-Residence at the Texas Medical Center Innovation Institute, as well as an
Honorary Research Fellow with The University of Melbourne, The University of Adelaide and Deakin University.
"I was drawn to CNSDose because of the staggering burden that untreated depression places on
people and on our economy, and the profound impact we can make." Mark is a senior healthcare
informatics executive who has led global companies, health tech start-ups, growth companies, IPO's
and strategic acquisitions. He has long focused in personalized and precision medicine utilizing
machine learning, AI and behavioural science to improve health outcomes. An experienced CEO, he
has held senior positions with companies such as NantHealth (global genomic medicine company),
Fiserv, HCA, Cigna, CorVel, and Global Care Quest plus Board positions with several precision
Hayden is an internationally experienced software developer. He brings a depth of software development
experience from a wide range of industries, web related technologies, coding languages, and systems
methodologies. He’s led the delivery of projects at large corporate, private agency, and startup
levels. Hayden has significant international experience, including being IT lead for GE Capital
where he won multiple highly competitive awards for software engineering excellence. He brings both
technical experience and excellent inter-personal communication skills to spearhead development of
both the CNSDose software platform and growth of the CNSDose software development team.
Ajeet (MD, PhD, MPsych, FRANZCP) is an academic private psychiatrist who was awarded his medical degree,
masters, and doctorate from The University of Melbourne. His research has focused on genetically
guided prescribing (pharmacogenetics) of antidepressants, particularly the role of the
blood-brain-barrier. He’s an academic member of the Clinical Pharmacogenetics Implementation
Consortium (CPIC) and member of the Genetic Tests in Psychiatry Taskforce, International Society of
Psychiatric Genetics (ISPG). Dr. Singh is also the Founder of CNSDose.
Andrew is the former Federal Trade Minister of Australia. He held the Federal seat of Goldstein from 2004
till his retirement from politics in 2016. In 2003 he was awarded the Office of the Order of
Australia (AO) for his services to agriculture, politics and the community. In the 1980’s he was
Executive Director of the Cattle Council of Australia, and later, Executive Director of the
National Farmers' Federation. He has an Agricultural Science and First Class Honours Degree in
Economics. Andrew served as a director of The Garvan Institute for Medical Research, Australia. He
provides strategic advice on trade and investment, serving on the boards of several major
Australian and International companies.
John (MD, MBChB, BSc, DPM, FRACP, FRANZCP, GAICD) is the immediate past Head of the Department of
Psychiatry and Professor Emeritus, The University of Melbourne. He’s an internationally respected
academic and clinical psychiatrist, with over 300 publications. He has a particular interest in the
quality treatment of depressive illness. John is also an experienced Company Director and active
member of the Australian Institute of Company Directors (AICD). He continues in clinical practice
and to teach at the University of Melbourne. He is an examiner for the flagship AICD Company
Directors Course - helping to set and maintain standards for directors in all areas of directorship.
Dr Samuel Soo (MD) is a board certified OBGYN, Molecular Diagnostician, and Medical Entrepreneur based in Melbourne, Australia. Dr Soo was previously superintendent of Westmead Hospital (Sydney's busiest hospital). As well as being a director of CNSDose, Dr Soo is a Clinical Director of Melbourne IVF and Executive member of Epworth Hospital (a prestigious private Melbourne hospital). He has seen firsthand the rapid growth in genetic technology in his own field - where he was an early clinical and commercial adopter. He sees immense clinical application in other areas, especially mental health – spurning his strong and early interest in CNSDose.